China DongSheng International, Inc. engages in the manufacture and development of nutritional supplements, and beauty care and alternative health care products. The company is headquartered in Jilin, Jilin and currently employs 86 full-time employees. The company went IPO on 2008-09-30. The Company’s main business is engaged in the development of two lithium-in-clay projects located in northern Tanzania and West End Lithium project located near Tonopah, Nevada, with the aim of producing and selling lithium carbonate. The Company’s projects include Titan One Lithium Project, Titan Two Lithium Project and West End Lithium Project.
根據最新的財務報表(Form-10K),China Dongsheng International Inc 的總資產為 $41,淨利潤為 $10
CDSG 的關鍵財務比率是什麼?
China Dongsheng International Inc 的流動比率為 2.05,淨利潤率為 32.25,每股銷售為 $2.76。
China Dongsheng International Inc 的收入按細分市場或地理位置如何劃分?
China Dongsheng International Inc 最大收入來源為 Vision Care,在最近的收益報告中收入為 2,923,000,000。就地區而言,U.S. and Puerto Rico 是 China Dongsheng International Inc 的主要市場,收入為 2,546,000,000。
China Dongsheng International Inc 是否盈利?
是的,根據最新的財務報表,China Dongsheng International Inc 的淨利潤為 $10